Armando Sardi, MD
Surgical Oncology · Baltimore, MDNPI 1679511570
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Johnson & Johnson at 27.5% of the total.
Across 85 payments — averaging $27.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$647
- Eisai Inc.$189
- Springworks Therapeutics, Inc.$164
- Novartis$130
- Baxter Healthcare$123
- AbbVie$109
- plus $991 from 22 others
What the payments were for
- Food & beverage$2,353100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $647 |
| Eisai Inc. | 8 | $189 |
| Springworks Therapeutics, Inc. | 3 | $164 |
| Novartis | 8 | $130 |
| Baxter Healthcare | 3 | $123 |
| AbbVie | 5 | $109 |
| Medtronic | 2 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| E.r. Squibb & Sons, L.L.C. | 4 | $88 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $85 |
| Hologic Sales And Service, LLC | 2 | $74 |
| Merck | 4 | $58 |
| Sanofi | 2 | $46 |
| EMD Serono, Inc. | 2 | $44 |
| Angiodynamics, Inc. | 2 | $43 |
| Covidien LP | 1 | $43 |
| Foundation Medicine, Inc. | 2 | $35 |
| Integra Lifesciences Corporation | 1 | $34 |
| Kerecis Limited | 1 | $29 |
| Tempus AI, Inc | 1 | $28 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $27 |
| Nestle Healthcare Nutrition Inc. | 1 | $26 |
| Avanos Medical | 1 | $22 |
| Abbott | 1 | $22 |
| TEI Biosciences Inc | 1 | $21 |
| Getinge USA Sales, LLC | 1 | $21 |
| Shire North American Group Inc | 1 | $18 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OGSIVEO$113
How this compares
$2,353 in reported general payments places this provider in the 80th percentile of 40 surgical oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Baltimore
- Kerri LopezBaltimore$16K
- Rebecca BrownBaltimore$13K
- Arun MavanurBaltimore$4K
- Lisa JacobsBaltimore$2K
- Daria AbolghasemiBaltimore$2K
- Richelle WilliamsBaltimore$2K
- Humair QuadriBaltimore$1K
- Kelly LafaroBaltimore$945
- Ray Gervacio BlancoBaltimore$502
- Jeremy DavisBaltimore$376
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.